Private Sector to Expand Production of ARC FMD Vaccine Using ARC IP

The ARC is allowing qualifying private companies to use its intellectual property to manufacture the FMD vaccine at scale. This decision comes as the council also expands its own vaccine production capacity, aiming to increase overall availability.

Originally published by gnews